Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Electronic (PDF)Add to Basket
Live Chat Live Help Software for Website

Apotex, Inc. - Strategic SWOT Analysis Review

GlobalData, Aug 2011, Pages: 28


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

Apotex, Inc. - Strategic SWOT Analysis Review

Summary

Apotex, Inc. (Apotex) is a pharmaceutical company engaged in the research, development, manufacture and distribution of generic drugs. The company produces more than 300 generic pharmaceuticals in approximately 4,000 dosages and formats. Additionally, it develops, manufactures and distributes fine chemicals, non-prescription and private label medicines, and disposable plastics. Its Pharmaceuticals are exported to over 115 countries worldwide. The company operates through its subsidiaries, joint ventures and licensing agreements in Australia, Belgium, Czech Republic, Italy, Mexico, the Netherlands, New Zealand, Poland, Turkey, and the UK. Its Canadian operations are carried out from manufacturing facilities spanning over 3.4 million square feet in Montreal, Richmond Hill, Toronto, Etobicoke, Mississauga, Brantford, Windsor, Winnipeg, London, Calgary and Vancouver. The company is headquartered in Toronto, Ontario, Canada.

Apotex, Inc. Key Recent Developments…

May 10, 2011: Apotex Resumes Shipping To US
Mar 30, 2011: Pronova BioPharma Reaches Agreement With Apotex Regarding Lovaza US Patent Litigation
Sep 21, 2010: Mylan Granted Temporary Restraining Order Against GSK And Apotex Regarding Generic Version Of Paxil CR
Jan 21, 2010: Apotex Donates $2 Million Medicines To Haiti Earthquake Relief

GlobalData’s Apotex, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.



Customers who bought this item also bought

Pronova BioPharma ASA (PRON) - Financial and Strategic SWOT Analysis Review

Mylan Inc. (MYL) - Financial and Strategic SWOT Analysis Review

Apotex, Inc. - Strategy and SWOT Report

Mylan Inc.: PharmaVitae Profile

Mylan Inc. - Strategy and SWOT Report

Apotex Inc.: PharmaVitae Profile

Mylan Inc. - Strategy, SWOT, and Corporate Finance Report

Watson Pharmaceuticals, Inc. (WPI) - Financial and Strategic SWOT Analysis Review

Mylan Inc.: SWOT Analysis & Company Profile

Mylan Inc.: PharmaVitae Model



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds